We are live on ! Find out more
HCM

Highline Capital Management Portfolio holdings

AUM $53.5M
1-Year Est. Return 21.72%
This Fund
S&P 500
This Quarter Est. Return
+38.24%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
AUM
$123M
AUM Growth
-$288M
Cap. Flow
-$347M
Cap. Flow %
-282.17%
Top 10 Hldgs %
73.36%
Holding
33
New
8
Increased
1
Reduced
10
Closed
14

Top Buys

Rank Stock Value
1
PASG icon
Passage Bio
PASG
+$6.26M
2
SPLK
Splunk Inc
SPLK
+$6.15M
3
MA icon
Mastercard
MA
+$5.47M
4
CB icon
Chubb
CB
+$4.45M
5
EXAS
Exact Sciences
EXAS
+$4.04M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$35M
2
AMZN icon
Amazon
AMZN
+$34M
3
VRSN icon
VeriSign
VRSN
+$29.1M
4
BABA icon
Alibaba
BABA
+$25.6M
5
CRM icon
Salesforce
CRM
+$25.5M

Sector Composition

Rank Sector Weight
1 Healthcare 33.24%
2 Technology 23.09%
3 Consumer Discretionary 21.63%
4 Financials 11.88%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PASG icon
1
Passage Bio
PASG
$15.9M
$17.7M 14.38%
32,380
+13,913
+75% +$6.26M
AMZN icon
2
Amazon
AMZN
$2.5T
$14.2M 11.52%
102,740
-281,460
-73% -$34M
CHTR icon
3
Charter Communications
CHTR
$14.7B
$8.84M 7.18%
17,322
-49,328
-74% -$25M
AVTR icon
4
Avantor
AVTR
$7.81B
$8.15M 6.62%
479,270
-1,111,730
-70% -$18.1M
ATVI
5
DELISTED
Activision Blizzard
ATVI
$7.76M 6.31%
102,285
-331,765
-76% -$23.1M
SPLK
6
DELISTED
Splunk Inc
SPLK
$7.72M 6.27%
+38,854
New +$6.15M
VRSN icon
7
VeriSign
VRSN
$25.3B
$6.94M 5.64%
33,563
-140,117
-81% -$29.1M
BABA icon
8
Alibaba
BABA
$269B
$6.88M 5.59%
31,887
-122,970
-79% -$25.6M
CTLT
9
DELISTED
CATALENT, INC.
CTLT
$6.12M 4.98%
83,530
-515,910
-86% -$35M
CRM icon
10
Salesforce
CRM
$134B
$5.98M 4.86%
31,925
-151,310
-83% -$25.5M
MA icon
11
Mastercard
MA
$477B
$5.74M 4.66%
+19,395
New +$5.47M
TJX icon
12
TJX Companies
TJX
$170B
$5.56M 4.52%
109,945
-134,555
-55% -$6.76M
CB icon
13
Chubb
CB
$140B
$4.86M 3.95%
+38,418
New +$4.45M
EXAS
14
DELISTED
Exact Sciences
EXAS
$4.4M 3.58%
+50,609
New +$4.04M
RNR icon
15
RenaissanceRe
RNR
$13.7B
$4.02M 3.27%
+23,506
New +$3.86M
ANGI icon
16
Angi Inc
ANGI
$224M
$3.01M 2.44%
+24,749
New +$2.26M
ADPT icon
17
Adaptive Biotechnologies
ADPT
$3.56B
$2.76M 2.24%
+57,081
New +$2.08M
ALEC icon
18
Alector
ALEC
$164M
$1.77M 1.44%
72,499
-3,315
-4% -$91.5K
PCG icon
19
PG&E
PCG
$47.8B
$665K 0.54%
+75,000
New +$817K
ARCT icon
20
Arcturus Therapeutics
ARCT
$157M
-56,304
Closed -$765K
CALM icon
21
Cal-Maine
CALM
$4.28B
-452,900
Closed -$19.9M
CMC icon
22
Commercial Metals
CMC
$7.63B
-1,281,542
Closed -$20.2M
CRWD icon
23
CrowdStrike
CRWD
$187B
-793,600
Closed -$11M
DG icon
24
Dollar General
DG
$25.9B
-145,000
Closed -$21.9M
DHT icon
25
DHT Holdings
DHT
$2.97B
-1,625,383
Closed -$12.5M

Similar funds

Highline Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Highline Capital Management held 33 positions worth $123M, down 70% from $411M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Highline Capital Management withdrew a net $347M in Q2 2020, closing 14 positions and reducing 10 holdings. Its most notable exit was Dollar General, an estimated $21.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Highline Capital Management opened a new position in Splunk Inc worth $7.72M.

  • Highline Capital Management's largest Q2 2020 buy was Splunk Inc: 38,854 shares worth $7.72M.
  • Highline Capital Management added most to Passage Bio in Q2 2020, an estimated $6.26M increase.
  • Highline Capital Management's biggest Q2 2020 reduction was CATALENT, INC., cutting an estimated $35M.
  • Highline Capital Management fully exited Dollar General in Q2 2020, selling an estimated $21.9M.
  • Highline Capital Management's ten largest holdings make up 73% of its $123M portfolio in Q2 2020.
  • Highline Capital Management opened 8 new positions and closed 14 in Q2 2020.
  • Highline Capital Management's portfolio value fell 70% quarter-over-quarter to $123M.

Based on Highline Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.